Service Provisions

AXIOS Senolytics is an R&D oriented specialty pharmaceutical company dedicated to the development and commercialization of senolytic compounds, dietary supplements and drugs against aging, age-related degenerative diseases and cancer.

AXIOS Senolytics develops and operates an existing portfolio of senolytic drug candidates (trademarks, patents, industrial property rights) and leverages its research through partnership agreements with major pharmaceutical companies, both in the form of R&D contracts and licensing agreements per therapeutic application.

AXIOS Senolytics also offers its customers and partners a wide range of consulting and expertise services, from scientific and regulatory support for R&D projects to the development of specific products and formulas.

For more information about our services, please contact our sales department at or by telephone on +33 (0)